Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $14.40 million. The enterprise value is $499,840.

Market Cap	14.40M
Enterprise Value	499,840

Important Dates

The next estimated earnings date is Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 7.02 million shares outstanding. The number of shares has increased by 22.97% in one year.

Current Share Class	7.02M
Shares Outstanding	7.02M
Shares Change (YoY)	+22.97%
Shares Change (QoQ)	+58.61%
Owned by Insiders (%)	7.42%
Owned by Institutions (%)	2.08%
Float	3.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.25
P/TBV Ratio	3.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.73

Current Ratio	15.73
Quick Ratio	15.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.78% and return on invested capital (ROIC) is -40.62%.

Return on Equity (ROE)	-58.78%
Return on Assets (ROA)	-35.30%
Return on Invested Capital (ROIC)	-40.62%
Return on Capital Employed (ROCE)	-41.66%
Revenue Per Employee	n/a
Profits Per Employee	-$364,873
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.57% in the last 52 weeks. The beta is 0.38, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-52.57%
50-Day Moving Average	2.10
200-Day Moving Average	2.51
Relative Strength Index (RSI)	53.03
Average Volume (20 Days)	33,441

Short Selling Information

The latest short interest is 28,919, so 0.41% of the outstanding shares have been sold short.

Short Interest	28,919
Short Previous Month	13,592
Short % of Shares Out	0.41%
Short % of Float	0.78%
Short Ratio (days to cover)	0.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.47M
Pretax Income	-6.93M
Net Income	-5.84M
EBITDA	-6.39M
EBIT	-6.47M
Earnings Per Share (EPS)	-$1.55

Full Income Statement

Balance Sheet

The company has $13.90 million in cash and n/a in debt, giving a net cash position of $13.90 million or $1.98 per share.

Cash & Cash Equivalents	13.90M
Total Debt	n/a
Net Cash	13.90M
Net Cash Per Share	$1.98
Equity (Book Value)	15.54M
Book Value Per Share	0.90
Working Capital	13.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.72M
Capital Expenditures	n/a
Free Cash Flow	-5.72M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.97%
Shareholder Yield	-22.97%
Earnings Yield	-40.55%
FCF Yield	-39.76%

Analyst Forecast

The average price target for Edesa Biotech is $13.00, which is 534.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	534.15%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2